PRME

NASDAQStock

Prime Medicine, Inc.

$3.67-0.07 (-1.74%)

52-Week Range

$1.15

$6.67

Key Stats

Market Cap

661.6M

P/E Ratio

—

Dividend Yield

—

Beta

2.58

Volume

1.5M

Avg Volume

3.4M

Performance

+12.35%

-7.67%

-6.98%

YTD

+5.67%

+108.38%

-71.26%

-76.33%

Price Chart

ETF Exposure

PRME is held by 80 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	2,694	$10K	$1.43B	0.09%
SPYI.DE	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	9,300	$26K	$4.48B	0.17%
USFM.L	UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.00%	330	$1K	$134.4M	0.25%
VTHR	Vanguard Russell 3000 ETF	0.00%	9,108	$35K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	3,120,450	$11.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	16,412	$85K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,415	$7K	$1.29B	0.17%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	10,029	$37K	$40.55B	0.17%
DFAS	Dimensional - US Small Cap ETF	0.00%	305	$1K	$12.65B	0.26%
DFUS	Dimensional - US Equity Market ETF	0.00%	2,164	$8K	$18.51B	0.09%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	8	$32	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	28	$106	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	47	$180	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	54	$207	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	64	$245	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	53	$204	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	35	$135	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	27	$102	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	12	$45	$9.3M	0.12%
IWV	iShares Russell 3000 ETF	0.00%	10,452	$40K	$17.30B	0.20%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	2,441	$10K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	2,441	$10K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	2,441	$10K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	153	$792	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	5,481	$28K	$12.17B	0.24%
VETS	Pacer Military Times Best Employers ETF	0.00%	2,441	$10K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	2,441	$10K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	26	$136	$337.7M	0.32%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	190,186	$57K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	190,186	$17K	$3.91B	0.07%

PreviousPage 2 of 2

About PRME ETF Exposure

Prime Medicine, Inc. (PRME) is held by 80 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 661.6M, PRME is a widely held institutional stock. The stock currently trades at $3.67. Investors can gain exposure to PRME through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PRME, sorted by portfolio weight.